Adverse Events Associated with Amlodipine: A Pharmacovigilance Study Using the FDA Adverse Event Reporting System

Xingwei Di^1*Jiazhen Jiang²Qian Zhong³Xinyu Zhou²Lisi Zhou⁴Jiyuan Zheng²Bingshuo Liu⁵

• ¹Department of Cardiovascular Medicine, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
• ²The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China
• ³Department of Cardiovascular Medicine, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China
• ⁴Clinical Medical College of Acupuncture, Moxibustion and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, China
• ⁵The Fifth Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China

In accordance with the International Committee of Medical Journal Editors (ICMJE) guidelines, in order to be included in the author list a contributor must meet all 4 of the following criteria:• Substantial contributions to the conception or design of the work;or the acquisition, analysis, or interpretation of data for the work; AND• Drafting the work or revising it critically for important intellectual content; AND• Final approval of the version to be published; AND• Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.Any contributors who meet fewer than all 4 of the above criteria for authorship must not be listed as authors, but their contributions should be detailed in the Acknowledgments section. Requests to add authors who do not meet all 4 of the above criteria will not be considered. We ask authors to use the CRediT taxonomy to clearly describe their contributions to papers. Please see CRediT for more details.If you have any questions regarding authorship, contact the Research Integrity team of the relevant journal.Please note that we cannot proceed with the publication of your manuscript until any outstanding authorship issues have been resolved.Completing and signing the form• Complete and submit an Authorship Change form if you: add, remove, or change the order of the authors after your article is accepted.• We only accept forms written in English, signatures can be provided in Arabic and Chinese.• Complete the form with all article and author information, and new statements (on Page 3), if they have changed.• Complete the last page of the form with the final author list that will be used in the published article.• The form must be signed individually, by each author.• The form should be manually signed or contain valid e-signatures (an electronic version of a signature that can be uniquely identified and linked to the signatory, as shown in the example below).• Useful link: helpx.adobe.com/acrobat/using/signing-pdfs.html.• Authors can submit signatures across different files individually if the main information is completed and all signatures are provided.• Digital stylus.• Adobe "drawn" (using the default fonts) and "signed" signatures.• Signature stamps or seals.• Handwritten signatures.• Typed signatures which are not e-signatures will not be accepted.• Signatures which have been signed on behalf of other authors/not individually signed. • Photographs of signatures will also not be allowed.If you provide the form with invalid signatures, we will not be able to accept it or be able to consider your request for an authorship change. • 如果您在文章接收后， 需要： 添加、 删除或更改作者的顺序， 请填写并提交作者身份变 更表.• 请您用英文填写表格， 签名可以是中文.• 请将所有文章和作者的信息填写在表格中； 如果添加或者删除作者， 请在第3页填写新 的声明.• 在表格的最后一页填写最终作者名单， 该名单将用于在线发表版本中.• 表格必须由每位作者单独签名.• 表格必须提供手写签名或包含有效的电子签名 (可以唯一识别并链接到签名人的电子 版签名， 如下例所示) .• 有效的链接： helpx.adobe.com/acrobat/using/signing-pdfs.html.• 如果作者因地域原因不能同时在同一个文件签名， 可分别在不同文件填写完整信息， 并单独完成签名.• 数字化签名.• Adobe (使用默认字体) "绘制 (drawn) " 和 "签署 (signed) " 的签名.• 印章签名.• 手写签名.• 不接受非电子签名的打字签名. Provide the author list in the order that you would like it to be published and with the correct spelling.